Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) EBITDA Margin: 2009-2024

Historic EBITDA Margin for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to 4.86%.

  • Pediatrix Medical's EBITDA Margin rose 104700.0% to 14.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.47%, marking a year-over-year increase of 209500.0%. This contributed to the annual value of 4.86% for FY2024, which is 19100.0% down from last year.
  • Latest data reveals that Pediatrix Medical reported EBITDA Margin of 4.86% as of FY2024, which was down 19100.0% from 2.95% recorded in FY2023.
  • Pediatrix Medical's 5-year EBITDA Margin high stood at 6.74% for FY2021, and its period low was 45.74% during FY2020.
  • For the 5-year period, Pediatrix Medical's EBITDA Margin averaged around 8.74%, with its median value being 2.95% (2023).
  • In the last 5 years, Pediatrix Medical's EBITDA Margin crashed by -564400bps in 2020 and then soared by 524700bps in 2021.
  • Over the past 5 years, Pediatrix Medical's EBITDA Margin (Annual) stood at 45.74% in 2020, then skyrocketed by 115bps to 6.74% in 2021, then plummeted by -54bps to 3.11% in 2022, then plummeted by -195bps to 2.95% in 2023, then tumbled by -65bps to 4.86% in 2024.
  • Its EBITDA Margin was 4.86% in FY2024, compared to 2.95% in FY2023 and 3.11% in FY2022.